Measuring Heart Blood Supply Balance in People with High Blood Pressure
Studies a non-invasive pulse test to measure heart blood supply in adults with hypertension.
Plain-language title generated from the registry record
Registry title: Subendocardial Viability Ratio in Hypertension
Key facts
- Where
- Bari, Mascalucia, Milan, Reggio Emilia, and Trieste, ItalySee the 5 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with high blood pressure (hypertension). Their heart's blood supply is measured with a non-invasive pulse test on the artery (arterial tonometry).
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Hypertension (high blood pressure). No stage or severity is given.
Main reasons for not taking part
- Atrial fibrillation
Read by machine on 12 November 2026.
Where in Italy
- Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa "Anna Maria Pirrelli", Università degli Studi di Bari "Aldo Moro". Policlinico Consorziale di BariBari, ItalyContact: Pietro Nazzaro, MDTaking people
- Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi"Mascalucia, ItalyContact: Antonino Di Guardo, MDTaking people
- Istituto Auxologico Italiano IRCCSMilan, ItalyContact: Paolo Salvi, MDTaking people
- Medicina II Cardiovascolare, AUSL-IRCCS di Reggio EmiliaReggio Emilia, ItalyContact: Angelo Ghirarduzzi, MDTaking people
- Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di TriesteTrieste, ItalyContact: Andrea Grillo, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Istituto Auxologico Italiano
- Trial code
- NCT06309511
- Record updated
- 3 August 2025
- Original description
The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension.Read full original descriptionShow less
Subendocardial Viability Ratio in Hypertension
The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension.
The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry.
The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI (diastolic pressure-time index), i.e. the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase, and the SPTI ( systolic pressure-time index), i.e. the area under the carotid pressure curve during the systolic phase.
The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database.
Inclusion: Hypertension.
Exclusion: Atrial fibrillation.